Ovoca Bio PLCMUN Ovoca Bio Stock Report

Ovoca Bio Plc is a clinical-stage biopharmaceutical company. The company is headquartered in Dublin, Dublin and currently employs 10 full-time employees. The firm is developing a treatment for premenopausal women with hypoactive sexual desire disorder (HSDD). The company is focused on women's health and identifying candidates in areas of unmet medical need. The firm's lead product, Orenetide (BP-101), is a synthetic peptide administered through nasal spray. The spray delivers the drug to the olfactory and trigeminal nerves in the nasal cavity, where the drug accumulates in the olfactory bulb and further in the brain. The company is developing a new treatment for women affected by low libido or sex drive. The firm's subsidiaries include Silver Star Ltd., Bulun LLC, Magsel LLC, IVIX LLC, and OVB (Australia) Pty Ltd, among others. The firm operates in Ireland, the United Kingdom and Russia.